EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ivermectin for Malaria Vector Control: Mechanisms and Clinical Evidence

Nurul Ain, Mike Permata Sari, Afifa Radhina

Health & Medical Sciences · 18.11.2026 · 4 (1) · 19-31

DOI: 10.47134/phms.v4i1.810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health & Medical Sciences, online erschienen am 18.11.2026. Verfasst von Nurul Ain und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ivermectin kills Anopheles mosquitoes feeding on treated hosts and is being evaluated as a complementary malaria vector control tool. This narrative review synthesizes evidence regarding glutamate-gated chloride channels (GluCl), mosquito-lethal human metabolites, effects on Plasmodium sporogony, and clinical trial outcomes. A structured PubMed search identified mechanistic, entomological, pharmacokinetic, and clinical studies published primarily between 2016 and 2026. Laboratory studies demonstrate biological plausibility, showing mosquito mortality and impaired sporogony. Human metabolites also contribute significantly to mosquitocidal activity. However, population-level evidence remains inconsistent. While a Kenyan trial demonstrated reduced malaria infection incidence, the Mozambique BOHEMIA trial faced operational disruptions, and RIMDAMAL II in Burkina Faso showed no significant incidence reduction when combined with seasonal malaria chemoprevention. Furthermore, a 2026 meta-analysis confirmed stronger evidence for mosquito mortality than for consistent epidemiological benefits. Thus, ivermectin is a promising investigational adjunct rather than a replacement for core interventions. Future research must standardize endpoints, optimize dosing, and evaluate context-specific effectiveness.

Zitieren

APA

Ain, N., Sari, M. P., & Radhina, A. (2026). Ivermectin for Malaria Vector Control: Mechanisms and Clinical Evidence. Health & Medical Sciences, 4(1), 19-31. https://doi.org/10.47134/phms.v4i1.810

Vancouver

Ain N, Sari MP, Radhina A. Ivermectin for Malaria Vector Control: Mechanisms and Clinical Evidence. Health & Medical Sciences. 2026;4(1):19-31. doi:10.47134/phms.v4i1.810

BibTeX
@article{Ain2026,
  author = {Ain, Nurul and Sari, Mike Permata and Radhina, Afifa},
  title = {Ivermectin for Malaria Vector Control: Mechanisms and Clinical Evidence},
  journal = {Health & Medical Sciences},
  year = {2026},
  volume = {4},
  number = {1},
  pages = {19--31},
  doi = {10.47134/phms.v4i1.810}
}
Kostenlos starten →